Abstract

Successful research and development cooperation between a textile research institute, the German Federal Ministry of Education and Research via the Center for Biomaterials and Organ Substitutes, the University of Tübingen, and the Burn Center of Marienhospital, Stuttgart, Germany, led to the development of a fully synthetic resorbable temporary epidermal skin substitute for the treatment of burns, burn-like syndromes, donor areas, and chronic wounds. This article describes the demands of the product and the steps that were taken to meet these requirements. The material choice was based on the degradation and full resorption of polylactides to lactic acid and its salts. The structure and morphology of the physical, biological, and degradation properties were selected to increase the angiogenetic abilities, fibroblasts, and extracellular matrix generation. Water vapor permeability and plasticity were adapted for clinical use. The available scientific literature was screened for the use of this product. A clinical application demonstrated pain relief paired with a reduced workload, fast wound healing with a low infection rate, and good cosmetic results. A better understanding of the product’s degradation process explained the reduction in systemic oxidative stress shown in clinical investigations compared to other dressings, positively affecting wound healing time and reducing the total area requiring skin grafts. Today, the product is in clinical use in 37 countries. This article describes its development, the indications for product growth over time, and the scientific foundation of treatments.

Highlights

  • A balance of these properties would allow the the product to be used for partial-thickness burns, supporting wound healing and the reproduct to be used for partial-thickness burns, supporting wound healing and the regenergeneration of the epithelium without generating granulation tissue

  • A fully synthetic and fully resorbable epidermal template based on lactic acid, a physiological and essential product of the human metabolism, opened a new product line and eliminated complicated and laborious production steps

  • Biocompatibility has been achieved before in other products by the genetic modification of animal-derived tissue [129], which remains limiting in terms of viral, bacterial, and prion safety

Read more

Summary

Introduction

Denkendorf and Stuttgart Burn Center at the Clinic for Orthopedics, Trauma Surgery and Sports Traumatology of Marienhospital, Stuttgart, Germany, was formed within the scope of the BMOZ (German Center for Biomaterials and Organ Substitute Stuttgart–Tübingen), supported by the German Federal Ministry of Education and Research, the Federal Country of Baden-Württemberg, and the University of Tübingen to develop a material “combining the advantages of biological and synthetic substitutes” [1,2]. This material was needed to advance skin substitution processes to improve burn and wound care.

The Choice of Materials
The Chemical Structure
The Material Structure
Material Properties
Medical of the development
Results of Development
Pain Reduction
Reduction in the Oxidative Stress and the Systemic Inflammatory Response
The Practical Meaning of the Reduction in Oxidative Stress
Donor Areas
Superficial and Partial-Thickness Burns
Partial-Thickness and Small Third-Degree Burns
Full-Thickness Burns
Cost-Effectiveness
Limitations
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call